IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 130 filers reported holding IVERIC BIO INC in Q2 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $23,184,000 | -37.8% | 2,409,961 | +8.8% | 4.90% | -41.1% |
| Q1 2022 | $37,278,000 | -30.7% | 2,214,961 | -31.2% | 8.33% | -33.2% |
| Q4 2021 | $53,791,000 | +20.4% | 3,217,163 | +17.0% | 12.46% | +5.8% |
| Q3 2021 | $44,662,000 | +304.9% | 2,750,137 | +57.3% | 11.78% | +206.4% |
| Q2 2021 | $11,031,000 | +3.2% | 1,748,241 | +1.1% | 3.84% | -9.7% |
| Q1 2021 | $10,685,000 | +21.4% | 1,729,041 | +35.7% | 4.26% | -11.1% |
| Q4 2020 | $8,805,000 | – | 1,274,261 | – | 4.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |